about
Structural Basis for Universal Corrinoid Recognition by the Cobalamin Transport Protein HaptocorrinComparison of recombinant human haptocorrin expressed in human embryonic kidney cells and native haptocorrinDOTA-functionalized polylysine: a high number of DOTA chelates positively influences the biodistribution of enzymatic conjugated anti-tumor antibody chCE7aglEvaluation of ¹¹¹in-labelled exendin-4 derivatives containing different meprin β-specific cleavable linkersFDG kinetic modeling in small rodent brain PET: optimization of data acquisition and analysisSyntheses and characterization of dicarbonyl-nitrosyl complexes of technetium(I) and rhenium(I) in aqueous media: spectroscopic, structural, and DFT analyses.Water-exchange study revealed unexpected substitution behavior of [(CO)2(NO)Re(H2O)3]2+ in aqueous media.Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies.Evaluation of anti-VEGFR-3 specific scFv antibodies as potential therapeutic and diagnostic tools for tumor lymph-angiogenesis.Modification of different IgG1 antibodies via glutamine and lysine using bacterial and human tissue transglutaminase.Organometallic [Re(CO)3]+ and [Re(CO)2(NO)]2+ labeled substrates for human thymidine kinase 1.A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelatorEfficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society.Current use and future potential of organometallic radiopharmaceuticals.Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse modelLongitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering.Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model.In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model.PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues.Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis.Prospects in folate receptor-targeted radionuclide therapyMetal chelating systems synthesized using the copper(I) catalyzed azide-alkyne cycloaddition.Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.Folate receptor targeted alpha-therapy using terbium-149.Single photon emission computed tomography tracer.First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.Microbial transglutaminase and c-myc-tag: a strong couple for the functionalization of antibody-like protein scaffolds from discovery platforms.Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models.Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.Synthesis and biological evaluation of (18)F-labeled Fluoroethoxy tryptophan analogues as potential PET tumor imaging agents.Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential radionephropathy.Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.Synthesis and preliminary biological evaluation of O-2((2-[(18)F]fluoroethyl)methylamino)ethyltyrosine ([(18)F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging.Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine.Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.Expression of functional folate receptors by human parathyroid cells.
P50
Q27679057-E428212B-9240-430E-85E0-4928D2072368Q28483938-1F27A07D-0E17-44DC-A9AE-DAC4D5C7B0A3Q28485909-44C80092-8017-4E65-B745-C5EA798BC963Q28545983-29653C34-60DA-45A1-AE62-512F5789D5ADQ30659338-AD5DDB1A-F044-48B1-A583-22CDD998D275Q30981668-E793C189-C8F1-4BF0-9287-79B40E0D435EQ31039564-EBB094C7-6169-4331-A468-11AEC67AE555Q31095363-787E3A0B-6171-428C-8005-35F70543B655Q33297021-B1EAFAD8-24A4-42CE-A11B-3FB5476D6FDFQ33305264-0FF90125-F195-4F5E-93D4-4BA3624E3B77Q33435956-56E1162B-F557-4250-9AEA-C7867DE35C05Q33833281-74B5B743-EBF9-418A-9462-E056E69C912AQ34096303-8CCD9FC5-52A8-4451-B268-56312133B1C2Q34611425-570DCA9F-BE3D-46A6-A9E8-6249A0F14464Q34979217-E3C1EC66-4FA5-4213-9186-933DB832ACD2Q35057527-694325FD-F615-4AC1-938C-22AB05E0D3BAQ35623313-D675C8CE-B89E-4B6B-A99A-9C4AE9FD300EQ35675494-03F47DC2-3C14-43FA-B60C-D048874F3EA5Q36098586-01006B6D-9EB3-41BB-9582-0618D327D887Q36269747-E4E2B974-70A3-4C0D-A0CC-B33A5D86BE01Q36338484-CACEA419-60C1-4A35-A749-4134161F0FD1Q36426875-65EE18FB-F676-429A-A27C-BF457691DE49Q37193061-A36FBE24-8138-4A99-81AE-34C1307FAF10Q37672349-E4E3FD0B-631A-4B5D-A684-AB977F6528DFQ37689804-B76B95D3-9907-4272-B0AB-BBF506486104Q37689807-258FE751-8C84-4713-8325-51812BEDA969Q38062416-ED442B77-7B91-41CB-A848-F29D5F172E55Q38254309-F6767BDD-3DB8-4788-882B-F9759FB34B44Q38908797-F95BFE52-8F48-44AE-83CE-D30ABBF1B021Q38914737-43B17EA2-70D4-4C47-814F-36BBA52035D6Q38916078-C078A8D8-8322-47AA-AF40-111CDF333976Q38974576-C26E5491-35C2-4D69-824A-6612945E4B81Q38978731-F71F15A9-FC29-4410-8ED1-538AD1624E56Q38986060-5FBAC6BC-D132-4601-B547-855AC16F173EQ38991698-8A9537D5-DE9D-4727-8320-73989ADF5663Q38997841-D6BDAF52-3A76-4AFE-B3B0-3B62C9EB7462Q39028535-ADEBD384-8E0E-4BA2-BD79-EB1651D2E4F9Q39048536-5C4306FB-175A-4736-910A-98B1BBE8CF93Q39062639-5117427B-A88D-47E6-BFBE-FD2F50E51982Q39065605-EAB8AC74-0D27-4840-9D08-F9E2146A243C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Roger Schibli
@ast
Roger Schibli
@en
Roger Schibli
@es
Roger Schibli
@sl
type
label
Roger Schibli
@ast
Roger Schibli
@en
Roger Schibli
@es
Roger Schibli
@sl
prefLabel
Roger Schibli
@ast
Roger Schibli
@en
Roger Schibli
@es
Roger Schibli
@sl
P106
P21
P31
P496
0000-0002-1537-3833